Perceive Biotherapeutics
Latest round
- Series B
Last raised
- Feb 2025
Total raised
- $55M
Investors
- 6
About Perceive Biotherapeutics
Based in California, US, and founded in 2020, Perceive Biotherapeutics, Inc. operates as a healthcare platform that engages in developing a therapeutic technology that could help patients with eye diseases. In February 2025, Perceive Biotherapeutics, Inc. As of January 2023, K. Angela Macfarlane, JD is the Chief Executive Officer (CEO) of the company. Perceive Biotherapeutics is focused on the discovery and development of transformative gene therapies and other therapeutics for ocular diseases with high unmet needs that develop new eye care therapeutics to address major unmet patient needs. The company develops a channel of assets with differentiated targets using multiple therapeutic modalities, assisting medical professionals in preventing the leading causes of unpreventable blindness.
Who invested in Perceive Biotherapeutics
6 investors across 2 rounds
See all investors in Perceive Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Perceive Biotherapeutics
Who invested in Perceive Biotherapeutics?
Perceive Biotherapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Perceive Biotherapeutics raised?
Perceive Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Perceive Biotherapeutics last raise money?
Perceive Biotherapeutics's most recent round on record is a Series B, in Feb 2025.
What does Perceive Biotherapeutics do?
Based in California, US, and founded in 2020, Perceive Biotherapeutics, Inc.
Where is Perceive Biotherapeutics headquartered?
Perceive Biotherapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Perceive Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Perceive Biotherapeutics's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Perceive Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.